The Recall Desk

Manufacturer

Bristol-Meyers Squibb

1 recall in our database name Bristol-Meyers Squibb as the manufacturing or recalling firm.

What the numbers show

Total
1
Critical
1
Severe
0
Most recent
2014-09-24

Of the 1 recalls from Bristol-Meyers Squibb we have scored against our rubric, 1 (100%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 0 (0%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–1 of 1

  • CriticalFDA (Drugs)·D-1595-2014·2014-09-24

    Bristol-Myers Squibb Recalls Coumadin for Injection Due to Particulate Matter

    Bristol-Myers Squibb is recalling Coumadin for Injection vials because metallic-like and cellulose fiber particles were found in retained samples.

    Product
    COUMADIN FOR INJECTION (Warfarin Sodium for Injection, USP 5 mg Single-Use Vial Rx Only Distributed by Bristol Meyers Squibb Company, Princeton, NJ 08543 USA NDC 0590-0324-96
    Category
    Drug
    Distribution
    Distributed nationwide